<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>103(1)</volume><submitter>Voruz S</submitter><journal>Haematologica</journal><pagination>e39-e41</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5777214</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.</pubmed_title><pmcid>PMC5777214</pmcid><pubmed_authors>de Leval L</pubmed_authors><pubmed_authors>Naveiras O</pubmed_authors><pubmed_authors>Missiaglia E</pubmed_authors><pubmed_authors>Cairoli A</pubmed_authors><pubmed_authors>Michielin O</pubmed_authors><pubmed_authors>Homicsko K</pubmed_authors><pubmed_authors>Blum S</pubmed_authors><pubmed_authors>Voruz S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jan</publication><modification>2025-04-04T07:16:26.663Z</modification><creation>2025-04-04T07:16:26.663Z</creation></dates><accession>S-EPMC5777214</accession><cross_references><pubmed>29097496</pubmed><doi>10.3324/haematol.2017.179150</doi></cross_references></HashMap>